
|Articles|April 28, 2008
Actonel for osteoporosis cleared for use once per month
A new dosage form of once per month is now available for the osteoporosis drug Actonel.
Advertisement
Actonel (risedronate sodium), which is now available in daily, weekly, and two-tablets-per-month dosage forms, has now been approved for once a month (150 mg) administration. Co-promoted by Procter & Gamble and sanofi-aventis, the
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
2
General Awareness of PBM Practices Driving Optimism for Independent Pharmacies | NCPA 2025
3
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
4
FDA Releases Biosimilar Guidance Pushing to Streamline Development
5

























































































































































